Andrade, Daniel Ciampi De; Teixeira, Manoel Jacobsen; Mello, Evandro Sobroza de; Hoff, Paulo Marcelo Gehm; Dale, Camila Squarzoni 
; Brentani, Helena Paula
Fonte: Oncologist. Unidades: FM, ICB
Assuntos: NEOPLASIAS COLORRETAIS, QUIMIOTERAPIA, ANTINEOPLÁSICOS, DOENÇAS DO SISTEMA NERVOSO PERIFÉRICO, DOR
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
ANDRADE, Daniel Ciampi De et al. Pregabalin for the prevention of oxaliplatin-induced painful neuropathy: a Randomized, Double-Blind Trial. Oncologist, v. 22, n. 10, p. 1154-0, 2017Tradução . . Disponível em: https://doi.org/10.1634/theoncologist.2017-0235. Acesso em: 22 jul. 2024.APA
Andrade, D. C. D., Teixeira, M. J., Mello, E. S. de, Hoff, P. M. G., Dale, C. S., & Brentani, H. P. (2017). Pregabalin for the prevention of oxaliplatin-induced painful neuropathy: a Randomized, Double-Blind Trial. Oncologist, 22( 10), 1154-0. doi:10.1634/theoncologist.2017-0235NLM
Andrade DCD, Teixeira MJ, Mello ES de, Hoff PMG, Dale CS, Brentani HP. Pregabalin for the prevention of oxaliplatin-induced painful neuropathy: a Randomized, Double-Blind Trial [Internet]. Oncologist. 2017 ; 22( 10): 1154-0.[citado 2024 jul. 22 ] Available from: https://doi.org/10.1634/theoncologist.2017-0235Vancouver
Andrade DCD, Teixeira MJ, Mello ES de, Hoff PMG, Dale CS, Brentani HP. Pregabalin for the prevention of oxaliplatin-induced painful neuropathy: a Randomized, Double-Blind Trial [Internet]. Oncologist. 2017 ; 22( 10): 1154-0.[citado 2024 jul. 22 ] Available from: https://doi.org/10.1634/theoncologist.2017-0235
